EMCDDA Home
  • EN
Search

Table EYE-10. Recent school surveys (2005–2010): percentage lifetime prevalence of psychoactive substance use among students aged 15–16 years old

CountryYearReferenceProjectSample sizeCannabisInhalants/volatile substancesAmphetaminesEcstasyLSD and other hallucinogensCocaineHeroin
Belgium (Flemish)2008(7)VAD218623:33:3:
Belgium (Flemish)2009/10HBSC(WHO)122621::::::
Belgium (French speaking)2009/10HBSC(WHO)134120::::::
Bulgaria2007ESPAD235322366332
Czech Republic2007ESPAD390145735511
Czech Republic2009/10HBSC(WHO)152231::::::
Denmark(8)2007ESPAD87725655132
Denmark2009/10HBSC(WHO)122615::::::
Germany(2)2007ESPAD5011201153231
Germany2009/10HBSC(WHO)164011::::::
Estonia2007ESPAD237226946321
Estonia2009/10HBSC(WHO)139822::::::
Ireland2007ESPAD2221201534341
Ireland2009/10HBSC(WHO)169515::::::
Greece2007ESPAD30606932211
Greece2009/10HBSC(WHO)16487::::::
Spain(1)2008(8)PNSD1646033232341
Spain2009/10HBSC(WHO)200327::::::
France2007ESPAD2916311244253
France2009/10HBSC(WHO)190627::::::
Italy2010(6)ESPAD Italy1245712111121
Italy2009/10HBSC(WHO)154620::::::
Cyprus2007ESPAD634051633232
Latvia2007ESPAD2275181367421
Latvia2009/10HBSC(WHO)137525::::::
Lithuania2007ESPAD241118333221
Lithuania2009/10HBSC(WHO)179221::::::
Luxembourg2009/10HBSC(WHO)138219::::::
Hungary2007ESPAD281713845321
Hungary2009/10HBSC(WHO)173314::::::
Malta2007ESPAD3668131654241
Netherlands2007ESPAD209128624331
Netherlands2009/10HBSC(WHO)145721::::::
Austria(9)2007ESPAD2571171483231
Austria2009/10HBSC(WHO)182014::::::
Poland2007ESPAD212016644222
Poland2009/10HBSC(WHO)141019::::::
Portugal2007ESPAD314113422122
Portugal2009/10HBSC(WHO)155311::::::
Romania2007ESPAD22894411120
Romania2009/10HBSC(WHO)20029::::::
Slovenia2007ESPAD3085221623232
Slovenia2009/10HBSC(WHO)181523::::::
Slovakia2007ESPAD2468321326431
Slovakia2009/10HBSC(WHO)191417::::::
Finland2007ESPAD498881012111
Finland2009/10HBSC(WHO)21109::::::
Sweden 2009(9)CAN51927611111
United Kingdom2007ESPAD217929924351
United Kingdom (England)(3)(4)2009(11)NatCen/NFER1787271835252
United Kingdom (England)2009/10HBSC(WHO)111822::::::
United Kingdom (Scotland)(3)(4)2006(5)Scottish Gov.1198025535452
United Kingdom (Scotland)2009/10HBSC(WHO)256719::::::
United Kingdom (N.Ireland)(3)(4)2007(1)National Agency:171135451
United Kingdom (Wales)2009/10HBSC(WHO)163722::::::
Croatia2007ESPAD3008181122221
Croatia2009/10HBSC(WHO)242413::::::
Turkey(2)2003ESPAD41774422222
Norway2007ESPAD34826711111
Norway2009/10HBSC(WHO)13396::::::
United States of America(6)(7)2010(1)NIDA156003312116341

Notes:

 This table presents data on 15- to 16-year-old school students obtained from national surveys. The surveys for Belgium (Flemish ) is the Flemish region only, and the Germany and Turkish ESPAD is limited to the regions specified in the following notes. In all of the school surveys, the method for data collection was classroom-based, anonymous, self-completion questionnaires in written test conditions.         

 Caution is required comparing figures due to methodological limitations. For methods and definitions, see <a href="http://www.emcdda.europa.eu/stats11/eye/methods">Methods and definitions: youth and the schools population</a>.         

 <a href="http://www.espad.org">ESPAD</a> (European School Survey Project on Alcohol and Other Drugs) is coordinated by the Swedish Council for Information on Alcohol and Other Drugs (CAN) and the Council of Europe (Pompidou Group). ESPAD prevalence figures are taken from published ESPAD reports and may differ sometimes from those reported directly by Member States. The sample sizes given refer to the number of participating 15- to 16-year-old students who filled in the questionnaire.         

 (1) ESPAD methods are adopted to varying degrees.         

 (2) ESPAD 2007 Germany figures are based in seven regions only (Bavaria, Brandenburg, Berlin, Hesse, Mecklenburg-Western Pomerania, Saarland and Thuringia). ESPAD 2007 Belgium figures are based on Flanders only. ESPAD 2003 Turkey figures are based on one major city in each of six different regions (Adana, Ankara, Diyarbakir, Istanbul, Izmir and Samsun).          

 (3) The sample size given for these surveys is for a wider age range than 15 to 16 years.         

 (4) Only 15-year-old students are included in United Kingdom ONS and Scottish Executive school surveys.          

 (5) To be interpreted with caution as sample size is small and private and vocational schools are excluded.         

 (6) Inhalants are adjusted for under-reporting of butyl nitrites.         

 (7) Amphetamines includes only drug use not under a doctor's order.         

 (8) ESPAD 2007 data for Denmark has limited comparability.                 

 (9) The prevalence rate of amphetamine use in Austria has to be interpreted very cautiously because there are problems with data quality. A validation study found out, that the pupils mixed up amphetamines with energy drinks in several cases.         

 See also 'General notes for interpreting data' on the <a href="http://www.emcdda.europa.eu/stats11/help">Explanatory notes and help page</a>.           

Sources:

 See <a href="http://www.emcdda.europa.eu/stats11/eyetab0">Table EYE-0</a> for further information on sources.         

 Health Behaviour in School-aged Children (HBSC), International Coordinating Centre, Child and Adolescent Health Research Unit (CAHRU) School of Medicine, University of St Andrews, Medical and Biological Sciences Building, ST ANDREWS, Fife KY16 9TF <a href="http://www.hbsc.org">HBSC</a>         

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 11 November 2011